EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 27-Oct-2025 21:11 ET (28-Oct-2025 01:11 GMT/UTC)

New understanding of a decades-old bladder cancer treatment could help improve immunotherapies more broadly

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

A team of researchers from MSK and Weill Cornell Medicine is expanding the understanding of how a decades-old treatment for bladder cancer works — an understanding that could help improve the effectiveness of immunotherapies more broadly.

Journal: Cancer Cell
Funder: National Institutes of Health

Poorly functioning blood vessels lead to muscle wasting in cancer

University of Illinois Chicago
Peer-Reviewed Publication

A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients experience, according to a new study from University of Illinois Chicago researchers.

Journal: Nature Cancer

New insights into bladder cancer treatment could help improve immunotherapies

Weill Cornell Medicine
Peer-Reviewed Publication

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.

Now, a team of researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) and is expanding the understanding of how the treatment works — an understanding that could help improve the effectiveness of immunotherapies more broadly.

Journal: Cancer Cell

Most Americans unaware of cancer risks associated with drinking alcohol

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Alcohol is a leading preventable cause of cancer, but public awareness of the connection remains strikingly low in the U.S., with just 40% of American adults recognizing alcohol as a cancer risk, according to a new study from The University of Texas MD Anderson Cancer Center.

Journal: JAMA Oncology

Public awareness of the association between alcohol and cancer in the U.S.

JAMA Network
Peer-Reviewed Publication

About The Study: The findings of this study that fewer than half of U.S. adults are aware and about one-fifth are unsure of their awareness of the association between alcohol and cancer emphasize the need to implement the recently updated Surgeon General’s recommendation to reduce the alcohol-related cancer burden in the U.S.

Journal: JAMA Oncology

Acupuncture for nocturia in survivors of prostate cancer

JAMA Network
Peer-Reviewed Publication

About The Study: In this pilot trial, acupuncture produced greater reductions in nocturia (waking up 1 or more times to urinate) relative to usual care in survivors of prostate cancer. The nocturia reduction was comparable to other treatments, such as desmopressin, α-blockers, and antimuscarinic medications; however, acupuncture was associated with fewer adverse events. Nocturia affects more than half of survivors of prostate cancer.

Journal: JAMA Oncology

Genetics and therapy type determine second cancer risk after childhood treatment

St. Jude Children's Research Hospital
Peer-Reviewed Publication

Scientists at St. Jude Children’s Research Hospital have found that genetics and type of cancer treatment contribute most to a survivor’s risk of a second cancer.

Journal: The Lancet Oncology

Menopause drug Duavee may help prevent invasive breast cancer, clinical trial finds

Northwestern University
Reports and Proceedings

A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new findings from a multi-center phase 2 clinical trial led by Northwestern Medicine.

Meeting: 2025 ASCO Annual Meeting

Two WCM scientists receive inaugural Pershing Square Foundation Ovarian Cancer Challenge Grant

Weill Cornell Medicine
Grant and Award Announcement

Dr. Juan R. Cubillos-Ruiz, the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology, and Dr. David Lyden, the Stavros S. Niarchos Professor in Pediatric Cardiology, both from Weill Cornell Medicine, have been named inaugural recipients of the Pershing Square Foundation’s 2025 Ovarian Cancer Challenge Grant.

Researchers find promise in a new peptide drug to combat a deadly brain cancer

Virginia Tech
Peer-Reviewed Publication

A lab-designed molecule developed and extensively studied by scientists with Virginia Tech’s Fralin Biomedical Research Institute at VTC could represent a breakthrough in slowing tumor recurrence in glioblastoma, an aggressive and deadly form of brain cancer.

Journal: Cell Death and Disease
Funder: NIH/National Cancer Institute, NIH/National Heart, Lung and Blood Institute, NIH/National Heart, Lung and Blood Institute